𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Golimumab trough levels, antidrug antibodies and clinical response in patients with rheumatoid arthritis treated in daily clinical practice

✍ Scribed by Kneepkens, E. L.; Plasencia, C.; Krieckaert, C. L.; Pascual-Salcedo, D.; van der Kleij, D.; Nurmohamed, M. T.; Lopez-Casla, M. T.; Wieringa, R.; Rispens, T.; Wolbink, G.


Book ID
126512568
Publisher
BMJ Publishing Group
Year
2014
Tongue
English
Weight
515 KB
Volume
73
Category
Article
ISSN
0003-4967

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Development of antiinfliximab antibodies
✍ Gerrit Jan Wolbink; Marijn Vis; Willem Lems; Alexandre E. Voskuyl; Els De Groot; πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 80 KB πŸ‘ 2 views

## Abstract ## Objective Treatment of patients with infliximab, a chimeric monoclonal IgG1 antibody against tumor necrosis factor, may result in the formation of infliximab‐specific IgG antibodies. This study evaluated the clinical significance of these antibodies in patients with rheumatoid arthr